Arteriovenous Malformations: Clinical Trials

11 trials for Arteriovenous Malformations, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 1 active not recruiting, 1 not yet recruiting, 1 recruiting. 11 Phase 1, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 111Completed 6, Active not recruiting 1, Not yet recruiting 1, Recruiting 1, Unknown 1, Withdrawn 1
Phase 24Completed 2, Active not recruiting 1, Recruiting 1

Follow Arteriovenous Malformations: new trials by email Literature Review of Arteriovenous Malformations trials Research Report on Arteriovenous Malformations

Trials (filtered) newest first · largest first

All 11 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Harmony-HHT: ATV-1601 in Participants With Hereditary Hemorrhagic Telangiectasia (HHT)
ATV-1601, Placebo - Hereditary Hemorrhagic Telangiectasia (HHT), Osler Weber Rendu Disease
Phase 1 / Phase 2RecruitingAtavistik Bio, Inc1002026-07-272026-10-29
A Trial of TER-1754 in Patients With Hereditary Hemorrhagic Telangiectasia
TER-1754, Placebo - Hereditary Hemorrhagic Telangiectasia (HHT)
Phase 1WithdrawnTerremoto Biosciences Inc.2025-12-152026-04-13
In Situ Injection of Anti-angiogenics in Patients With Brain Arteriovenous Malformations Not Eligible for Exclusion Treatment
Single in situ intra-arterial injection of bevacizumab - Brain Arteriovenous Malformations
Phase 1Not yet recruitingAssistance Publique - Hôpitaux de Paris202025-10-012025-07-20
Assess Safety and Efficacy of VAD044 in HHT Patients
VAD044 Part I, VAD044 Part II - Hereditary Hemorrhagic Telangiectasia (HHT)
Phase 1 / Phase 2Active not recruitingVaderis Therapeutics AG752022-07-182026-03-17
COmbiNing Cutting and Drug-Eluting Balloon for Resistant Arteriovenous Fistula sTenOsis (CONCERTO)
Angioplasty - Arteriovenous Fistula Stenosis
Phase 1CompletedSingapore General Hospital192018-08-152023-07-27
Clinical Translation of a Novel Albumin-Binding PET Radiotracer 68Ga-NEB
68Ga-NEB - Arteriovenous Malformation, Hemangioma
Phase 1UnknownPeking Union Medical College Hospital702014-01-012017-04-07
A Phase 1-2 Study of PRT-201 Administered in Chronic Kidney Disease (CKD) Patients
PRT-201 - Chronic Kidney Disease
Phase 1 / Phase 2CompletedProteon Therapeutics662008-11-012015-04-30
Influence of MMP on Brain AVM Hemorrhage
Doxycycline or Placebo - Arteriovenous Malformations, Cavernous Angiomas
Phase 1CompletedUniversity of California, San Francisco332008-03-012013-08-09
Safety of Vascugel Treatment After Creation of Arteriovenous Access for Hemodialysis Use
Vascugel, Placebo Comparator - Hemodialysis Access
Phase 1 / Phase 2CompletedPervasis Therapeutics, Inc652006-07-012011-10-27
Tetracycline-Derivatives for Treatment of Cerebral Arteriovenous Malformations and Aneurysms
minocycline, doxycycline - Aneurysms, Arteriovenous Malformations
Phase 1CompletedUniversity of California, San Francisco262004-07-012013-10-09
Phase I Drug Trial for S/E of Marimastat in Disabling Malformations When no Other Options.
Marimastat - Vascular Anomalies
Phase 1CompletedBoston Children's Hospital92000-10-012008-01-09

Narrower conditions

Arteriovenous Fistula (3)  ·  Telangiectasia, Hereditary Hemorrhagic (3)  ·  Vascular Malformations (2)  ·  Anemia (1)  ·  Aneurysm (1)  ·  Cardiovascular Diseases (1)  ·  Constriction, Pathologic (1)  ·  Disease (1)  ·  Epistaxis (1)  ·  Fistula (1)  ·  Hemangioma (1)  ·  Hemangioma, Cavernous (1)  ·  Hematologic Diseases (1)  ·  Hemorrhagic Disorders (1)

Broader conditions

Cardiovascular Abnormalities (11)  ·  Congenital Abnormalities (11)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (11)  ·  Cardiovascular Diseases (10)  ·  Vascular Diseases (10)  ·  Vascular Malformations (9)  ·  Hemic and Lymphatic Diseases (6)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Pathologic Processes (4)  ·  Hematologic Diseases (3)  ·  Hemorrhagic Disorders (3)  ·  Hemostatic Disorders (3)  ·  Pathological Conditions, Anatomical (3)  ·  Vascular Fistula (3)

Interventions

Doxycycline (2)  ·  68Ga-1,4,7-triazacyclononane-N,N',N''-triacetic acid (1)  ·  Angioplasty (1)  ·  Capsules (1)  ·  Minocycline (1)  ·  Single Person (1)  ·  cholesterol-binding protein (1)  ·  marimastat (1)

Sponsors

University of California, San Francisco (2)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Atavistik Bio, Inc (1)  ·  Boston Children's Hospital (1)  ·  Peking Union Medical College Hospital (1)  ·  Pervasis Therapeutics, Inc (1)  ·  Proteon Therapeutics (1)  ·  Singapore General Hospital (1)  ·  Terremoto Biosciences Inc. (1)  ·  Vaderis Therapeutics AG (1)

Countries

United States (8)  ·  France (2)  ·  Belgium (1)  ·  China (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Singapore (1)  ·  Spain (1)

Top investigators

Chanhung Lee, MD (1)  ·  Damien Picard (1)  ·  Fang Li, Dr. (1)  ·  Kun Da Zhuang, MBBS (1)  ·  Steven J Fishman, M.D. (1)  ·  William L. Young, MD (1)

Results publications

PMID 18212521, PMID 23172172, PMID 41297007

NIH funding

2023 (1), ZIAEB000073 (1)